Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer
Clinical trial NCT02980341 · COMPLETED
Trial details
- NCT number
- NCT02980341
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-28
- Primary completion
- 2021-08-16
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.